Glycogen Storage Disease Type II (GSD II) Completed Phase 3 Trials for Alglucosidase alfa (DB01272)
Also known as: Glycogen Storage Disease Type II GSD II / Glycogen Storage Disease Type II (GSD-II)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0041318 (Glycogen Storage Disease Type II (GSD II)) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00268944 | Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support | Treatment | |
| NCT00158600 | A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease | Treatment |